Microsubthalamotomy effect at day 3: Screening for determinants

Movement Disorders

Volumn 24, Issue 2, 2009, Pages 286-289

  Maltête, David ^a,b   Chastan, Nathalie ^a   Derrey, Stéphane ^a   Debono, Bertrand ^a   Gérardin, Emmanuel ^a   Lefaucheur, Romain ^a   Mihout, Bruno ^a   Hannequin, Didier ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Deep brain stimulation; Microsubthalamotomy; Parkinson's disease; Subthalamic nucleus

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

ADULT; AGE; AGED; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN SURGERY; CLINICAL ARTICLE; DISEASE DURATION; DYSKINESIA; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; MALE; MATTIS DEMENTIA RATING SCALE; MICROELECTRODE; MICROSUBTHALAMOTOMY; MOTOR DYSFUNCTION; PARKINSON DISEASE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RATING SCALE; SUBTHALAMIC NUCLEUS; THERAPY EFFECT; TISSUE REACTION;

ADOLESCENT; ADULT; AGED; ANTIPARKINSON AGENTS; BRAIN EDEMA; COMBINED MODALITY THERAPY; CONTRAST MEDIA; DEEP BRAIN STIMULATION; DYSKINESIAS; FEMALE; HUMANS; HYPOKINESIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE RIGIDITY; PARKINSON DISEASE; POSTOPERATIVE PERIOD; RADIOGRAPHY, INTERVENTIONAL; SEVERITY OF ILLNESS INDEX; STEREOTAXIC TECHNIQUES; THALAMUS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREMOR;

EID: 61649090725     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22380     Document Type: Article

References (19)

1. Deuschl G, Herzog J, Kleiner-Fisman G, et al. Deep brain stimulation: postoperative issues. Mov Disord 2006;21(Suppl.14): S219-S237.
2. Maltête D, Derrey S, Chastan N, et al. Microsubthalamotomy: an immediate predictor of long-term subthalamic stimulation efficacy in Parkinson disease. Mov Disord 2008;23:1047-1050.
3. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantation (CAPIT). Mov Disord 1992; 7:2-13.
4. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factor of subthalamic stimulation in Parkinson's disease. Brain 2002;125:575-583.
5. Jaggi JL, Umemura A, Hurtig HI, et al. Bilateral stimulation of the subthalamic nucleus in Parkinson's disease: surgical efficacy and prediction of outcome. Stereotact Funct Neurosurg 2004;82: 104-114.
6. Pahwa R, Wilkinson SB, Overman J, Lyons KE. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease. Stereotact Funct Neurosurg 2005;83:80-83.
7. Fahn S, Elton R, Members of UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson's disease, Vol. 2. NewYork: Macmillan; 1987. p 153-163.
8. Houeto JL, Welter ML, Bejjani PB, et al. Subthalamic stimulation in Parkinson disease: intraoperative predictive factors. Arch Neurol 2003;60:690-694.
9. Voges J, Volkmann J, Allert N, et al. Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson's disease: correlation of therapeutic effect with anatomical electrode position. J Neurosurg 2002;93:269-279.
10. Zonenshayn M, Sterio D, Kelly PJ, Rezai AR, Beric A. Location of the active contact within the subthalamic nucleus in the treatment of idiopathic Parkinson's disease. Surg Neurol 2004;62:216-226.
11. Benazzouz A, Tai CH, Meissner W, Bioulac B, Bezard E, Gross C. High-frequency stimulation of both zona incerta and subthalamic nucleus induces a normalization of basal ganglia metabolic activity in experimental parkinsonism. Faseb J 2004;18:528-530.
12. Godinho F, Thobois S, Magnin M, et al. Subthalamic nucleus stimulation in Parkinson's disease: anatomical and electrophysiological localization of active contacts. J Neurol 2006;253:1347-1355.
13. Hilker R, Voges J, Weber T, et al. STN-DBS activates the target area in Parkinson disease: an FDG-PET study. Neurology 2008; 71:708-713.
14. Counelis GJ, Simuni T, Forman MS, Jaggi JL, Trojanowski JQ, Baltuch GH. Bilateral subthalamic nucleus deep brain stimulation for advanced PD: correlation of intraoperative MER and postoperative MRI with neuropathological findings. Mov Disord 2003; 18:1062-1064.
15. Jarraya B, Bonnet AM, Duyckaerts C, et al. Parkinsons' disease, subthalamic stimulation, and selection of candidates: a pathological study. Mov Disord 2003;18:1517-1520.
16. Nielsen MS, Bjarkam CR, Sorensen JC, Bojsen-Moller M, Sunde NA, Ostergaard K. Chronic subthalamic high-frequency deep brain stimulation in Parkinson's disease - a histopathological study. Eur J Neurol 2007;14:132-138.
17. Alvarez L, Macias R, Guridi J, et al. Dorsal subthalamotomy for Parkinson's disease. Mov Disord 2001;16:72-78.
18. Su PC, Tseng HM, Liu HM, Yen RF, Liou HH. Treatment of advanced Parkinson's disease by subthalamotomy: one year results. Mov Disord 2002;18:531-538.
19. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997;337:1036-1042.